Regulatory T Cells in Elderly Patients With Asthma by Mota-Pinto, Anabela et al.
J Investig Allergol Clin Immunol 2011; Vol. 21(3): 199-206 © 2011 Esmon Publicidad
ORIGINAL ARTICLE
Regulatory T Cells in Elderly Patients With 
Asthma
A Mota-Pinto,1 A Todo1,2 V Alves,3 A Santos,2 M Santos3
1Institute of Pathophysiology, Faculty of Medicine, University of Coimbra, Portugal
2Immuno-Allergology Department, Coimbra University Hospital, Coimbra, Portugal
3Institute of Immunology, Faculty of Medicine, University of Coimbra, Portugal
■ Abstract
Background: Airway walls in asthma present an accumulation of activated cells that determine bronchial structural changes and disease 
progression and severity. During the aging process, the immunoinfl ammatory response changes as a consequence of chronic antigenic stress. 
Objective: To evaluate T-cell subsets with regulatory functions associated with asthma in elderly patients.
Methods: A group of 153 individuals (95 with controlled asthma and 58 healthy controls) aged over 65 years was studied. Blood samples were 
collected for fl ow cytometry analyses of CD3, CD4, CD8, CD56, CD56CD8, CD3CD4CD25, CD3CD4CD25CD127, CD4HLA-DR and TCRγδ.
Results: Asthmatic patients showed a statistically signifi cant increase in CD4+ T cells. CD3CD4CD25high and CD3CD4CD25highCD127high cells 
were also signifi cantly increased in asthmatic patients, while CD3CD4CD25highCD127low cells had similar values in asthmatics and in the 
control group. CD4HLA-DR cells were within the normal range in both groups. A positive correlation between CD3CD4CD25highCD127low 
and CD4HLA-DR was observed and γδ T cells were signifi cantly decreased in the asthmatic patients compared to the controls. 
Conclusions: Since T cells with regulatory functions were within normal ranges or reduced in asthmatic patients compared to healthy 
controls, at least in basal conditions, it can be speculated that they probably play a limited role in chronic asthma in elderly patients. These 
data suggest an absence of a modulatory effect on the infl ammatory response that characterizes asthma and allergy, which in turn would 
facilitate the persistence of disease in this population. Underlying infl ammatory processes that are involved in chronic diseases associated 
with aging could provide an additional explanation for the attenuated differences observed between asthmatic and nonasthmatic individuals. 
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■ Resumen
Antecedentes: En el asma, las paredes de las vías respiratorias presentan una acumulación de células activadas que determinan las 
alteraciones bronquiales estructurales, así como la progresión y la gravedad de la enfermedad. Durante el proceso de envejecimiento, la 
respuesta inmunoinfl amatoria se altera a causa del estrés antigénico crónico. 
Objetivo: Evaluar los subconjuntos de linfocitos T con funciones reguladoras asociados con el asma en pacientes ancianos.
Métodos: Se estudió a 153 personas (95 con asma controlada y 58 controles sanos) mayores de 65 años. Se obtuvieron muestras de sangre 
para análisis de citometría de fl ujo de CD3, CD4, CD8, CD56, CD56CD8, CD3CD4CD25, CD3CD4CD25CD127, CD4HLA-DR y TCRγδ.
Resultados: Los pacientes asmáticos mostraron un aumento estadísticamente signifi cativo de los linfocitos T CD4+. Los linfocitos 
CD3CD4CD25high y CD3CD4CD25highCD127high también aumentaron signifi cativamente en los pacientes asmáticos, mientras que los valores 
de linfocitos CD3CD4CD25highCD127low fueron similares en los pacientes asmáticos y en el grupo de control. Los linfocitos CD4HLA-DR 
estuvieron dentro del intervalo normal en ambos grupos. Se observó una correlación positiva entre los linfocitos CD3CD4CD25highCD127low 
y CD4HLADR, y los linfocitos T γδ disminuyeron signifi cativamente en los pacientes asmáticos en comparación con los controles. 
Conclusiones: Dado que los linfocitos T con funciones reguladoras estuvieron dentro de los intervalos normales o disminuyeron en los 
pacientes asmáticos en comparación con los controles sanos, al menos en las condiciones iniciales, es probable que tengan un papel limitado 
en el asma crónica en pacientes ancianos. Estos datos indican la ausencia de un efecto modulador sobre la respuesta infl amatoria que 
caracteriza al asma y la alergia, lo que a su vez facilitaría la persistencia de la enfermedad en esta población. Los procesos infl amatorios 
subyacentes que intervienen en las enfermedades crónicas asociadas con el envejecimiento proporcionan una explicación adicional para 
las diferencias atenuadas observadas entre personas asmáticas y no asmáticas. 
Palabras clave: Asma. Ancianos. Linfocitos Treg. Linfocitos T.
Asthma in the Elderly
 J Investig Allergol Clin Immunol 2011; Vol. 21(3): 199-206© 2011 Esmon Publicidad
Introduction
Asthma is a chronic infl ammatory disorder of the airways 
characterized by widespread but variable bronchial obstruction 
and hyper-responsiveness to several triggers. Asthmatic 
airway walls present an accumulation of activated eosinophils, 
lymphocytes, mast cells, macrophages, dendritic cells, and 
myofibroblasts, which, combined, determine bronchial 
structural changes and disease progression and severity [1]. 
Lung injury is a result of the balance between aggression and 
repair achieved through defence mechanisms that depend on 
the modulation of regulators [2]. The immunoinfl ammatory 
response changes during the aging process, assumedly as a 
consequence of the continuous damage caused by chronic 
antigenic stress throughout life. 
T cells and B cells are responsible for specifi c responses 
to antigen and have a central role in the immune system. 
Antigen stimulation of CD4+ T cells results in the activation 
and differentiation of these cells into several functional 
subsets [3]. Recent studies in T-cell biology have revealed 
a subset of CD4+ T cells that constitutively express high 
levels of CD25 (the interleukin [IL] 2 receptor α chain: 
CD4CD25high T cells) and the forkhead transcription factor 
FoxP3. These CD4CD25high cells can inhibit the activation of 
allergen-responsive T cells but this inhibitory effect is reduced 
in atopic patients [4]. These cells, known as regulator T cells, 
or Tregs, seem to play a central role in regulating infl ammation 
[4]. Moreover, uncontrolled pediatric asthmatics have lower 
CD4lowCD25high T cells in bronchoalveolar lavage fl uid than 
children treated with corticosteroids or healthy children [5]. 
The best cell surface activation marker is CD25, which is 
expressed not only in Treg cells but also in activated cells 
without regulatory functions. CD127, the α-chain of the IL-7 
receptor, is expressed on mature T cells and plays an important 
role in their proliferation. Since CD127 is absent on regulatory 
T cells and its expression is inversely correlated with FoxP3 
expression, regulatory CD4+ T cells expressing CD25 and/
or CD25high can be distinguished by a reduced expression of 
CD127. There is increasing evidence of an age-dependent 
development of Tregs. The number of CD4CD25high T cells 
in healthy individuals increases with age, particularly after 
60 years. Accumulation of memory-like CD45R0 Tregs may 
account for the trend towards increased CD4CCD25high Tregs 
observed in some studies of the elderly [6] and peripheral 
Treg production is likely to increase with the involution of 
the thymus [7,8]. According to in vitro studies, Treg 
cells have similar patterns of response in younger and 
older age groups [6]. Chronic quiescent inflammation, 
which is a recognized characteristic of elderly people, may 
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promote the occurrence of Treg cells, which may, in turn, 
facilitate a decline in adaptive response. This decline is 
characteristic of immunosenescence and is related to the 
gradual changes that occur in the immune system with age. 
These changes may be responsible for the frequent occurrence 
of immunoinfl ammatory respiratory diseases in the aging 
population [6,9,10]. 
Natural killer (NK) cells play an important role in the 
destruction of antigens and in the regulation of immune 
responses in a broad range of diseases including cancer. NK T 
(NKT) cells (CD56CD3) constitute a small subgroup of NK 
cells that express surface receptors of both T cells and NK 
cells [11,12]. Most (>75%) NKT cells are CD8+ and produce 
type 1 T helper (TH1) cytokines, with a regulatory effect on 
allergic infl ammation. The CD8CD56 NKT cell phenotype 
displays both antigen-specifi c cytolytic T cell activity, as 
well as NK-like cytolytic activities, which are independent 
of human leukocyte antigen class I and CD1 molecules. 
This major subset of NKT cells has potent cytolytic and 
immunoregulation functions. The elderly have elevated NKT 
cells and in particular an elevated NKTCD8 subpopulation [13].
T cells committed to γδ T cell receptor (TCRγδ) expression 
are present in the airways, where they offer important 
protection against infecting microorganisms. These γδ cells 
account for 1% to 10% of circulating mature lymphocytes and 
have been identifi ed in the airways of patients with rhinitis 
and asthma, suggesting that they might be involved in allergic 
airway infl ammation [14]. It has also been demonstrated 
that TCRγδ T cells can inhibit late airway allergic responses 
through the release of interferon (IFN) γ, playing an important 
role as regulators of airway infl ammation in immunoglobulin 
E– mediated diseases [15]. Furthermore, aging is characterized 
by a variety of alterations in γδ T-cell function and the absolute 
number of these circulating cells can be greatly reduced in the 
elderly [16,17].
The aim of this study was to compare, by fl ow cytometry 
analysis, blood T-cell subsets with regulatory tasks, such as 
CD4CD25highCD127low T cells, NKT cells, and γδ T cells in a 
group of elderly asthmatics and age-matched healthy controls.
Methods
Study Population
A group of 95 individuals aged over 65 years with 
controlled asthma attending an allergy clinic and an aged-
matched control group of 58 healthy volunteers were included 
in the study (Table 1). All the patients had a history of 
Table 1. Sex and Age Distribution in Elderly Asthmatics and Age-Matched Controls
Population No. Men/Women, Age, Mean Age Range,
  No. (SD), y y 
 
Control group 58 19/39 79 (7) 65-94
Asthmatic patients 95 32/63 72 (5) 65-87
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intermittent chest tightness, wheezing, or shortness of breath 
for at least 30 years prior to study enrolment consistent with 
the diagnosis of asthma according to the Global Initiative for 
Asthma (GINA) guidelines [18]. Patients with mild/moderate 
asthma were taking beclomethasone dipropionate (dose 
range, 250-500 μg) and those with severe asthma were taking 
fl uticasone propionate (250 μg) in association with long-acting 
ß2-agonists on a daily basis and short-acting ß2-agonists as 
needed. All other antiasthmatic drugs were withdrawn at least 
4 weeks prior to the study.
All patients were examined by a physician and underwent 
spirometry using the same equipment (Vitalograph Compact, 
Ennis, Ireland) at least 6 hours after the last dose of any 
bronchodilator. Predicted values were measured according to 
Knudson et al [19]. Spirometric performances were assessed 
by means of a computerized program following the American 
Thoracic Society (ATS) 94 criteria [20-22]. Approval for 
analysis was determined using the ATS 94 criteria and accuracy 
was achieved if 3 curves within the same evaluation were 
acceptable and reproducible.
All the patients and controls were nonsmokers, able to 
perform their own daily tasks, and physically active on a 
regular basis. None had had any respiratory infections in 
the month prior to inclusion in the study. No other clinically 
relevant diseases were reported. The following were 
considered exclusion criteria: cancer, autoimmune disease, 
infection, diabetes, heart failure, renal failure, chronic hepatic 
disease, and recent exposure to environmental risk factors for 
pulmonary diseases. Informed consent was obtained from all 
participants before enrolment.
Flow Cytometry 
The study of peripheral blood (PB) lymphocytes was 
performed using fl ow cytometry. Four milliliters of peripheral 
blood was drawn from the vein of the forearm into a tube 
with anticoagulant; 100 μL of PB was then incubated with 
monoclonal antibodies for 10 minutes at room temperature 
in the dark. 
To determine the main populations, a single tube with 
Lymphogram (Cytognos, Salamanca, Spain) containing anti-
CD4 monoclonal antibodies marked with phycoerythrin cyanin 
5 (Pecy5), CD8/CD19 stained with fl uorescein-isothiocyanate, 
and CD3/CD56 with phycoerythrin was used. The percentages 
of CD4+ or CD8+ cells are referred to as the CD3+ subset after 
the lymphocyte gate and the CD56+ cells are referred to as 
the CD3+ negative subset. The population analyzed (defi ned 
as CD56CD8) comprised CD56+ NK cells that co-expressed 
CD8. HLA-DR, TCR γδ (both from Immunotech, Marseille, 
France), CD8 (Dako, Denmark), and CD127 (BD Pharmingen, 
San Jose, California, USA) were stained with phycoerythrin. 
CD3 and CD4 with PeCy5 (Dako, Denmark), CD3 APC 
(Allophycocyanin), CD4 Percp (Peridinin chlorophyl protein) 
(BD Biosciences, San Jose, California, USA), and CD25 
fluorescein-isothiocyanate (Sanquin, Amsterdam, The 
Netherlands) were used according to the manufacturer’s 
instructions. The expression of CD25 and CD127 was analyzed 
using a lymphocyte gate.
Flow cytometry data were collected on a FACSCalibur 
fl ow cytometer (BD Biosciences) using CellQuest acquisition 
software and analyzed by Paint-a-gate software.
Statistical Analysis
Statistical analysis was performed using SPSS 12.0 
software. The Kolmogorov–Smirnov test was used to check 
for normal distribution. As all the variables were normally 
distributed the parametric t test was used to compare pairs 
of independent samples. P values of lower than .05 were 
considered signifi cant. Statistical comparisons were made 
between elderly asthmatics and healthy age-matched 
individuals. Differences between severe and mild/moderate 
asthmatic patients were also analyzed. 
Results
All the patients included in the study were clinically stable 
and 19 had a predicted forced expiratory volume in the fi rst 
second (FEV1) of less than 60%; 76 patients had a FEV1 of 
above 60%. The 19 patients were considered to have severe 
asthma and the remaining 76, mild or moderate asthma. The 
average lung function values of these 2 groups are shown in 
Table 2.
The mean percentages of the main blood cells subsets, 
CD3+, CD4+, and CD8+ T cells, were within normal ranges, 
although CD4+ cells were signifi cantly increased in asthmatic 
patients. The increase was more evident in the subgroup of 
patients with mild/moderate asthma (Figure 1 and Table 3). 
The percentage of NK cells expressing CD56 in asthmatic 
patients was slightly decreased but accounted for more than 
15% of PB mononuclear cells analyzed. The percentage of 
Table 2. Predicted Spirometric Valuesa in Elderly Asthmatic Patients
   No. of  %FEV1
 FEV1%  %FVC Tiffeneau
  Patients  after BD  Index
 
Severe asthma  19 51.8 (10.0) 10.2 (3.7) 68.1 (10.2) 70.1 (9.7)
Mild/moderate asthma 76 87.6 (17.8) 12.4 (6.2) 94.5 (15.5)   83.5 (13.0)
Abbreviations: BD, bronchodilation; FEV1, forced expiratory volume in the fi rst second; FVC, forced vital capacity; 
aPredicted values were measured according to Knudson [16] and are expressed as mean (SD).
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Figure 1. The mean (SD) percentage of CD3+ T cells in asthmatic patients 
(73.4% [7.6%]) was similar to that observed in the control group (73.6% 
[9.9%]). CD4+ T cells were signifi cantly increased in asthmatic patients 
(45.4% [9.6%]) compared to the control group (41.8% [10.4%]) (P<.05). 
CD8+ T cells were slightly but not signifi cantly lower in asthmatic patients 
(22.9% [8.0%]) compared to the control group (25.0% [9.5%]).
aCD4 T cells were signifi cantly increased in mild/moderate asthmatic patients. No 
signifi cant differences in CD56 and CD56CD8 cells were observed between patients 
with mild/moderate or severe asthma and healthy controls. CD3CD4CD25 T cells 
were significantly increased in patients with severe and mild/moderate asthma. 
CD3CD4CD25CD127 T cells and CD3CD4CD25highCD127high T cells were signifi cantly 
increased in patients with severe and mild/moderate asthma. No signifi cant differences 
in CD3CD4CD25highCD127low or γδ T cells were observed between patients with mild/
moderate or severe asthma and healthy controls.
bStatistically signifi cant difference (P<.05)
cNo statistically signifi cant difference.
Table 3. Cell Population Distribution According to Asthma Severity
 
  Healthy Patients With  Patients With
   Controls, % Severe Asthma, % Mild/Moderate
    Asthma, %
CD3  73.6 (9.9)b     74.2 (9.2)b 73.2 (7.5)b
CD4    41.8 (10.4)b       44.7 (10.0)b 45.6 (9.2)c
CD8  25.0 (9.5)b     24.8 (8.8)b 22.4 (7.7)b
CD56  16.2 (8.7)b               15.9 (8.3)b           14.8 (6.5)b
CD56CD8      5.9 (4.5)b       5.5 (2.4)b 5.4 (3.3)b
CD3CD4CD25high   4.4 (1.0)c       5.7 (2.1)c 5.4 (1.7)c
CD3CD4CD25highCD127   2.8 (0.9)       4.7 (2.5)c 4.1 (1.6)c
CD3CD4CD25highCD127high   1.7 (0.7)       2.9 (2.1)c 2.8 (1.2)c
CD3CD4CD25highCD127low   1.2 (0.4)       1.6 (1.0)b 1.3 (0.5)b
CD4HLA-DR      3.2 (1.7)       3.9 (4.0)b 3.9 (3.6)b
γδ     4.1 (3.3)       2.7 (2.1)b  3.0 (2.8/)b
NKT cells (CD56CD8) was also slightly decreased in asthmatic 
patients but no signifi cant differences were observed between 
groups (Figure 2 and Table 3).
Previous studies have analyzed the role of CD4CD25high T 
cells in immune regulation [2,4]. In our study, the percentage of 
CD3CD4+ cells expressing the IL-2 receptor (CD3CD4CD25high 
T cells) was signifi cantly increased in patients with both 
severe and mild/moderate asthma (Figure 3 and Table 3). 
Furthermore when the expression of CD127 in these subsets 
was tested, the percentage of CD3CD4CD25highCD127 and 
CD3CD4CD25highCD127high T cells was also signifi cantly 
increased in all asthmatic patients studied. On the contrary, 
the percentage of CD3CD4CD25highCD127low T cells, which 
were recently connected with a more accurate identifi cation of 
regulatory activity [21], was similar in asthmatic patients and 
in the control group. Within the group of asthmatic patients, 
disease severity did not alter the above results (Figure 4, Figure 
5, and Table 3).
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Figure 2. The mean (SD) percentage of CD56+ T cells in asthmatic patients 
was slightly decreased (15.0% [6.9%]) when compared to the control 
group (16.2% [8.7%]). CD56CD8+ T cells were also decreased in patients 
with asthma (5.4% [3.2%]) when compared to the control group (5.9% 
[4.5%]) (not signifi cant).
10
8
6
4
2
Control Asthma
CD3CD4CD25high
%
Figure 3. The mean (SD) percentage of CD3CD4CD25high T cells in 
asthmatic patients was signifi cantly increased (5.5% [1.9%]) when 
compared to the control group (4.4% [1.0%]) (P<.05).
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Figure 4. The mean (SD) percentage of CD3CD4CD25highCD127 and 
CD3CD4CD25highCD127high T cells was signifi cantly increased in asthmatic 
patients (4.2% [1.7%] and 2.8% [0.9%], respectively) when compared 
to the control group (1.7% [0.7%]) (P<.05). CD3CD4CD25highCD127low 
T cells were not signifi cantly different between asthmatic patients (1.4% 
[0.6%]) and the control group (1.2% [0.4%]).
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CD4HLA-DR T cells, which are believed to be upregulated 
during the cell activation process and to facilitate cell-to-cell 
communication were only slightly increased in the patient 
group (Figure 6 and Table 3). 
The small subset of γδ T cells that do not express the 
classical αβ receptors were significantly decreased in 
asthmatics (Figure 7 and Table 3). 
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Figure 5. Flow cytometry analysis of CD3CD4CD25highCD127low and 
CD3CD4CD25highCD127high T cells.
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Figure 6. The mean (SD) percentage of CD4HLA-DR T cells in asthmatic 
patients were slightly increased (3.9% [3.7]%) when compared to the 
control group (3.2% [1.7%]) (not signifi cant).
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Figure 7. The mean (SD) percentage of γδ T cells in asthmatic patients 
was signifi cantly decreased (2.9% [2.7%]) when compared to the control 
group (4.1% [3.3]) (P<.05).
Discussion
Asthma is a chronic infl ammatory disease of the airways 
that affects all age groups. While some patients experience 
complete recovery and resolution of symptoms, others have 
partial remission or develop progressive and irreversible 
obstruction of the airways, which, in extreme cases, can 
cause death. Asthma in the elderly is a disease with increasing 
prevalence in developed countries, where people over 65 
years account for over 20% of the population. The disabilities 
associated with this condition include not only respiratory 
distress but also cardiovascular events. Uncontrolled systemic 
infl ammation is claimed to be a major factor in the high 
morbidity and mortality observed [22]. The identifi cation 
of different regulatory cells that could dampen the immune-
infl ammatory process has opened several fi elds of investigation 
in these areas. 
T cells are the main modulators of infl ammatory response 
in asthma and play a key role in the eosinophilic infl ammation 
that characterizes the disease. Activated T cells can migrate into 
the airways and memory T cells then react to specifi c inhaled 
environmental antigens
The asthmatic patients analyzed in our study presented a 
signifi cant increase in CD4+ T cells compared to the healthy 
control group (P<.05). This may be associated with disease 
activity despite the long duration of the disease in the patients 
studied [1]. The slight decrease in CD8+ T cells in asthmatic 
patients refl ects the modest participation of these cells in 
asthma and their minor modulatory function [23]. 
Although it is widely accepted that TH2 cells are central to 
the pathogenesis of asthma, some studies have proposed that 
other T-cell subpopulations such as NKT cells may also play 
an important role in asthma [11,13]. NKT cells are usually 
well preserved throughout life, suggesting that in elderly 
individuals, these cells are kept at a high level of effi ciency, 
contributing to successful aging. NKT cells co-express a TCR 
and a variety of characteristic molecular markers, with major 
histocompatibility complex restriction. The NKT cell cytokine 
environment can determine the development of immune 
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regulatory activity (IL4) or dominant proinfl ammatory IFN-γ 
activity [24]. CD56CD8+ cells tend to increase with aging and 
in several chronic infl ammatory conditions such as neoplastic 
diseases or autoimmunity [25-27].
In the present study, CD56CD8+ cells were slightly reduced 
in asthmatic patients, with values of 5.4%, but they did not 
differ signifi cantly from the values observed in healthy age-
matched individuals. These data suggest that CD56CD8+ 
cells do not induce an eventual regulatory function in the 
infl ammatory process and do not assume a determinative role 
in chronic asthma affecting aged patients.
IL2, the greatest growth factor of T cells and an important 
marker of T-cell activation, regulate the expression of CD25 
(IL-2Rα). Recent advances in T-cell biology have led to the 
identifi cation of a subset of CD4+ T cells that constitutively 
express CD25 and FoxP3. These CD4CD25high cells, 
denoted Tregs, are involved in regulating and suppressing 
infl ammation [28]. Adoptive transfer of antigen-specifi c Tregs 
into allergen-sensitized mice has been seen to prevent allergic 
airway infl ammation and airway hyperresponsiveness [29]; 
these cells are therefore recognized as having the capacity to 
exert a suppressive effect on other cells of the immune system, 
maintaining tolerance in the periphery [30]. Natural regulatory 
cells have a minor presence in adults. Their suppressive 
response depends on the intensity of the stimulus generated 
and strong stimuli can overcome Treg cell surveillance. Natural 
Treg cells share many characteristics with activated cells, and 
activated CD4+ cells can positively regulate FoxP3 and acquire 
characteristics of regulatory cells [30]. The thymic involution 
associated with age, however, restricts the production and 
delivery of these cells.
In humans, CD4CD25high cells have a relatively long 
survival in spite of having short telomeres and limited 
proliferation. Indeed, they seem to be more resistant to 
apoptosis. The increased survival of regulatory cells leads to 
their accumulation in the elderly. In vitro studies have shown 
that these cells in cultures have equivalent suppressive activity 
in the young and in the elderly [6,9,31]. According to some 
authors, the proinfl ammatory environment can provide an 
important signal for the stimulation of regulatory cells, which 
also contributes to the immune suppression that characterizes 
the aging process [6,31].
In this study, a statistically significant increase in 
CD3CD4CD25high cells was observed in the group of elderly 
patients with asthma. CD25 upregulation can also occur 
in activated cells without regulatory functions [32]. The 
transcription factor Foxp3 has been reported to play a key 
role in CD4CD25high regulatory T cell function and represents 
a specifi c marker for these cells [33]. However, Foxp3 is 
a nuclear protein and is of limited value in the isolation 
of Tregs. In this study, we characterized regulatory CD4+ 
T cells expressing CD25high by their low expression of CD127. 
CD127low cells are suppressive with a low proliferative 
response to stimulation of TCR and rapid enhancement of 
FoxP3. Like other γ-chain cytokines, IL-7 confers optimal 
suppressive activity and maintains high FoxP3 expression of 
Tregs in vitro [33]. There are CD4CD25highCD127 T cells that 
express FoxP3. Nevertheless, after stimulation, the expression 
of CD127 decreases whereas that of FoxP3 increases, leading 
to the acquisition of suppressive ability [34,35]. The group 
of elderly asthmatic patients studied had increased values of 
CD3CD4CD25highCD127 and CD3CD4CD25highCD127high 
cells, and the differences were statistically significant 
when compared to the control population. The numbers of 
CD3CD4CD25highCD127low cells, considered to be regulatory 
cells, did not differ signifi cantly between asthmatic patients 
and healthy individuals. As CD127 may be specifically 
downregulated by FoxP3, its role in Treg homeostasis may 
be considered essential. Accordingly, it has been speculated 
that T cells with regulatory functions are not different in 
controlled asthmatics and healthy individuals, even when 
younger age groups are analyzed, at least in basal conditions, 
without exposure to common antigen [36]. This work follows 
the theory that even though activated CD4+ T cells may 
participate in chronic asthma when CD3CD4CD25high cells 
acquire characteristics of suppressive activity, they do not 
necessarily play an important role in this clinical condition, 
at least not in elderly patients. 
In our study, CD4HLA-DR cells were slightly though 
not signifi cantly increased in asthmatic patients compared 
to controls. Regulatory T cells that express HLA-DR have a 
more immediate and effective function in this task through 
direct contact between cells [37]. A positive correlation 
(Pearson correlation coefficient =0.46, P<.05) between 
CD3CD4CD25highCD127low cells and HLA-DRCD4 cells 
was observed in the group of patients. This study shows that 
patients with increased numbers of CD4+ T cells expressing 
CD25highCD127low cells also have increased numbers of CD4+ 
T cells expressing HLA-DR. These data allow us to speculate 
that, as previously suggested, the suppressive activity of CD4+ 
T cells might be enhanced by the expression of HLA class II 
molecules [38]. 
Although γδ T cells have been studied in detail over the 
last decade, their functionality and repertoire of antigenic 
activation have not yet been completely clarifi ed. γδ T-cell 
function contributes to cellular repair processes, which mainly 
depend on the surrounding environment. In asthma,  γδ T cells 
have predominantly anti-infl ammatory properties [14,39]. It 
has been demonstrated that stimulation of bronchial tissue with 
anti-TCR  γδ does not trigger the production of IL-5 and the 
ability of  γδ T cells to protect against bronchial hyperreactivity 
has also been documented [40]. The infectious processes 
trigger rapid and intense γδ T-cell activity, with inhibitory 
effects on the synthesis of IgE. These cells tend to decrease with 
age and this change is closely linked to increased susceptibility 
to the occurrence of infections, autoimmune diseases, cancer, 
and chronic infl ammatory processes characteristic of the 
elderly [41].
In this study, γδ T cells were signifi cantly reduced in 
patients with chronic asthma compared to the control group, 
which maintained a mean (SD) value of 4.0% (3.3%) (P<.05). 
The decrease observed refl ects the absence of a modulatory 
effect on infl ammatory response, which in turn, would facilitate 
the persistence of disease. Immunosenescence, which refers to 
natural immuno-infl ammatory changes that occur during the 
aging process, is assumed to be a consequence of the continuous 
damage caused by chronic antigenic stress throughout life. In 
this context it is accepted that the aging process underlies a 
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chronic infl ammatory status commonly termed infl ammaging. 
The reduced ability to downregulate the infl ammation that 
characterizes asthma and allergy is considered to contribute to 
the persistence of disease and suggests that the intervention of 
regulatory cells in chronic asthma in the elderly is moderate. 
In conclusion, asthma is a chronic infl ammatory disease of 
the airways characterized by eosinophil accumulation directed 
by TH2 cells that are recruited into the airways. However, 
other T-cell subsets such as NKT cells, Tregs, and γδ cells, 
which are widely accepted to exert a regulatory function, have 
been implicated. The exact function of these cells in asthma 
pathogenesis remains unclear. This study performed in elderly 
patients with asthma suggests that despite the persistence 
of CD4+ and CD3CD4CD25high cells in PB, the regulatory 
T-cell subsets investigated do not seem to have a signifi cant 
presence in chronic asthma in elderly individuals. It should be 
emphasized that despite the large number of patients enrolled 
in this study, disease severity did not introduce signifi cant 
differences in cell profi les. Infl ammaging may provide a 
continuous stimulus for regulatory cell development and for 
different T-cell networks in different age groups. Functional 
cell studies in the elderly are scarce and should be encouraged 
to increase knowledge in this area and possibly lead to new 
therapeutic strategies.
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